Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2

MLA

Kruse, C. A., et al. “Treatment of Recurrent Glioma with Intracavitary Alloreactive Cytotoxic T Lymphocytes and Interleukin-2.” Cancer Immunology, Immunotherapy, vol. 45, no. 2, Nov. 1997, pp. 77–87. EBSCOhost, https://doi.org/10.1007/s002620050405.

APA

Kruse, C. A., Cepeda, L., Owens, B., Johnson, S. D., Stears, J., & Lillehei, K. O. (1997). Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2. Cancer Immunology, Immunotherapy, 45(2), 77–87. https://doi.org/10.1007/s002620050405

Chicago

Kruse, C. A., Linda Cepeda, Betty Owens, Stephen D. Johnson, John Stears, and Kevin O. Lillehei. 1997. “Treatment of Recurrent Glioma with Intracavitary Alloreactive Cytotoxic T Lymphocytes and Interleukin-2.” Cancer Immunology, Immunotherapy 45 (2): 77–87. doi:10.1007/s002620050405.